Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017099079) NANOPARTICLE-WATER DISPERSION LIQUID OF GLYCOSPHINGOLIPID
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2017/099079 International Application No.: PCT/JP2016/086233
Publication Date: 15.06.2017 International Filing Date: 06.12.2016
IPC:
A61K 31/164 (2006.01) ,A61K 9/10 (2006.01) ,A61K 9/14 (2006.01) ,A61K 31/7028 (2006.01) ,A61K 47/36 (2006.01) ,A61K 47/38 (2006.01) ,A61P 37/02 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
16
Amides, e.g. hydroxamic acids
164
of a carboxylic acid with an aminoalcohol, e.g. ceramides
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
10
Dispersions; Emulsions
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
14
Particulate form, e.g. powders
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
7028
Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
30
Macromolecular compounds
36
Polysaccharides; Derivatives thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
30
Macromolecular compounds
36
Polysaccharides; Derivatives thereof
38
Cellulose; Derivatives thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37
Drugs for immunological or allergic disorders
02
Immunomodulators
Applicants:
株式会社レグイミューン REGIMMUNE CORPORATION [JP/JP]; 東京都中央区日本橋小伝馬町14番9号 14-9, Nihonbashi Kodenma-cho, Chuo-ku, Tokyo 1030001, JP
Inventors:
秋元 秀俊 AKIMOTO, Hidetoshi; JP
石井 保之 ISHII, Yasuyuki; JP
Agent:
田中 順也 TANAKA, Junya; JP
水谷 馨也 MIZUTANI, Keiya; JP
Priority Data:
2015-23883207.12.2015JP
Title (EN) NANOPARTICLE-WATER DISPERSION LIQUID OF GLYCOSPHINGOLIPID
(FR) LIQUIDE DE DISPERSION AQUEUSE DE NANOPARTICULES DE GLYCOSPHINGOLIPIDE
(JA) スフィンゴ糖脂質のナノ粒子水分散液
Abstract:
(EN) The purpose of the present invention is to provide a nanoparticle dispersion liquid of an α-galactosylceramide-related compound that can be administered in the form of a stable dispersion liquid using water as a solvent. According to the present invention, it is possible to obtain a nanoparticle dispersion liquid, which is not in the form of a liposome dispersion liquid obtained by using a phospholipid or the like, and also to control the size of nanoparticles.
(FR) L'objet de la présente invention est de fournir un liquide de dispersion de nanoparticules d'un composé apparenté au α-galactosylcéramide qui peut être administré sous forme d'un liquide de dispersion stable en utilisant de l'eau comme solvant. Selon la présente invention, il est possible d'obtenir un liquide de dispersion de nanoparticules, qui n'est pas sous la forme d'un liquide de dispersion de liposomes obtenu en utilisant un phospholipide ou analogue, et aussi de réguler la taille desdites nanoparticules.
(JA) 本発明の目的は、水を溶媒とした安定した分散液で投与できるα―ガラクトシルセラミド関連化合物のナノ粒子分散液を提供することである。 リン脂質等を用いてリポソームとして分散液にすることなく、ナノ粒子分散液を得ることができ、ナノ粒子のサイズも制御できる。
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)
Also published as:
EP3388059US20190000760